Avidity Biosciences Chief Medical Officer Jae Kim receives $7.4M in 2020
Avidity Biosciences reports 2020 executive compensation
By ExecPay News
Published: April 29, 2021
Avidity Biosciences reported fiscal year 2020 executive compensation information on April 29, 2021.
In 2020, three executives at Avidity Biosciences received on average a compensation package of $3.5M, a 22% decrease compared to previous year.
Average pay of disclosed executives at Avidity Biosciences
Jae B. Kim, Chief Medical Officer, received $7.4M in total. 95% of Kim's compensation, or $7M, was in option awards. Kim also received $50K in bonus, $99K in non-equity incentive plan, $192K in salary, as well as $349 in other compensation.
Michael F. MacLean, Chief Financial Officer, received a compensation package of $2.2M. 83% of the compensation package, or $1.9M, was in option awards.
Sarah Boyce, Chief Executive Officer, earned $823K in 2020, a 82% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2021.